|
CN104789644A
|
|
Method and kit used for detecting influences of X chromosome variation on Graves' disease susceptibility
|
|
CN104726539A
|
|
SRSF1P gene and application of its expression product
|
|
CN104726545A
|
|
RPS2P gene and application of its expression product
|
|
CN104726544A
|
|
PES1P gene and application of its expression product
|
|
CN104726541A
|
|
NFYAP1 gene and application of its expression product
|
|
CN104726543A
|
|
TOMM40P gene and application of its expression product
|
|
CN104726538A
|
|
FAM96AP gene and application of its expression product
|
|
CN104726542A
|
|
SELS gene and application of its expression product
|
|
CN104726540A
|
|
SLC25A15P3 gene and application of its expression product
|
|
CN104726546A
|
|
ENO1P gene and application of its expression product
|
|
CN104726537A
|
|
CENPK gene and application of its expression product
|
|
CN104651484A
|
|
Method and kit for detection of susceptibility of hyperthyroidism
|
|
CN104419748A
|
|
Method and kit for detecting susceptibility of ankylosing spondylitis by using genotype
|
|
CN104250656A
|
|
IRTKS gene-knocked out mouse model, construction method and application thereof
|
|
CN103571927A
|
|
Applications of human SAMD9L gene and protein product encoded by human SAMD9L gene
|
|
CN103540653A
|
|
Applications of homeobox A1 (HOXA1) gene and expression product thereof
|
|
CN103540654A
|
|
Applications of 11-19 lysine-rich leukemia (ELL) gene and expression product thereof
|
|
CN103290101A
|
|
Ago2 gene and application of expression product thereof
|
|
CN102988956A
|
|
Method and reagent for preventing, diagnosing, treating and prognosing bacterial infection-related diseases
|
|
CN102808016A
|
|
Applications of ARID1A gene and protein product encoded by the same
|
